You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial

 

Online download statistics by month:

Online download statistics by month: January 2024 to March 2026

AbstractFullPdf
Jan 2024651654268
Feb 2024270273170
Mar 2024226229161
Apr 2024183183130
May 202417117393
Jun 202413814178
Jul 202415015177
Aug 202412612762
Sep 202412812974
Oct 202414314385
Nov 2024147149192
Dec 202414615097
Jan 202514714770
Feb 202526226365
Mar 202517617880
Apr 202511611772
May 20259910658
Jun 2025646537
Jul 2025110
Aug 2025110
Mar 2026110
Total334633811869